The Effect and Mechanism of Curcumin Combined with Carboplatin Chemotherapy Promoting on Apoptosis of Lung Cancer HCC827 Cells

Overview

Journal J Immunol Res

Publisher Wiley

Specialty Allergy & Immunology

Date 2022 Aug 18

PMID 35979255

Authors

Lingping Huang

Xiangyuan He

Xuan Zuo

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the effect and mechanism of curcumin (CUR) killing lung cancer HCC827 cell spheres.

Method: HCC827 cell spheres were cultured in serum-free medium, and the protein expression of CD133, SOX2, EpCAM, and ABCG2 was detected by western blot. MTT was used to evaluate the cell viability of HCC827 cell spheres and HCC827 cell after they were treated by 1, 2, 5, 10, and 20 mg/mL carboplatin (CBP) for 48 h. The inhibitory effects of 10 M, 50 M, 100 M, and 200 M CUR on GST (glutathione S-transferase) activity in HCC827 cell spheres were determined by colorimetry. The flow cytometry (FCM), western blot, qPCR, luciferase assay, and microscopy were used to detect the ROS levels, cell pelletization ability, -catenin, SOX2, and ABCG2 mRNA and the promoter activity of -catenin upon of HCC827 cell spheres treated with 200 M CUR for 48 h. The HCC827 cell spheres were infected with -catenin adenovirus, and then cells were treated with 200 M CUR (and/or no 5 mg/mL CBP) for 24 h. The mRNA and protein expression of -catenin, SOX2, and ABCG2 was detected by qPCR and western blot, and cell growth inhibition of HCC827 cell spheres was evaluated by MTT.

Result: The expression of stem cells marker CD133, SOX2, EpCAM, and drug resistance-related gene ABCG2 mRNA is higher in HCC827 cell spheres, and HCC827 cell spheres resisted the killing effect of difference doses of CBP. The activity of GST of HCC827 cell spheres was inhibited by 10 M, 50 M, 100 M, and 200 M CUR. It was a dose-dependent manner. After 200 M CUR had treated HCC827 cell spheres for 48 h, the level of ROS was significantly increased ( < 0.05), and the mRNA and protein expression of -catenin, SOX2, and ABCG2 and promoter activity of -catenin were notably decreased ( < 0.05), compared to the control group. Furthermore, the formed-sphere ability of HCC827 sphere was inhibited after cells were treated with 200 M CUR. 200 M CUR could suppress the proliferation of HCC827 cell spheres and induced cell apoptosis. The proliferation of HCC827 cell spheres was significantly inhibited, and cell apoptosis rate was increased by 200 M CUR combined with 5 mg/mL CBP than by 200 M CUR alone. Upregulation of -catenin by adenovirus partly reversed the effect of CUR inhibition of the expression of -catenin, SOX2, and ABCG2, compared to empty vector adenovirus group. Additionally, overexpression of -catenin significantly remitted the inhibitory effect of 200 M CUR combined with 5 mg/mL CBP on the proliferation of HCC827 cell spheres.

Conclusion: CUR inhibited the cell proliferation and stem cell trait and induced apoptosis in HCC827 cell spheres by the inhibition of GST activity and -catenin expression. CUR is expected to become a treatment for lung cancer and lung cancer stem cells.

References

Yong X, Tang B, Xiao Y, Xie R, Qin Y, Luo G . Helicobacter pylori upregulates Nanog and Oct4 via Wnt/β-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer. Cancer Lett. 2016; 374(2):292-303. DOI: 10.1016/j.canlet.2016.02.032. View

Hayeshi R, Mutingwende I, Mavengere W, Masiyanise V, Mukanganyama S . The inhibition of human glutathione S-transferases activity by plant polyphenolic compounds ellagic acid and curcumin. Food Chem Toxicol. 2006; 45(2):286-95. DOI: 10.1016/j.fct.2006.07.027. View

Li F, Tiede B, Massague J, Kang Y . Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res. 2006; 17(1):3-14. DOI: 10.1038/sj.cr.7310118. View

Yang N, Hui L, Wang Y, Yang H, Jiang X . Overexpression of SOX2 promotes migration, invasion, and epithelial-mesenchymal transition through the Wnt/β-catenin pathway in laryngeal cancer Hep-2 cells. Tumour Biol. 2014; 35(8):7965-73. DOI: 10.1007/s13277-014-2045-3. View

Lyttle M, Hocker M, Hui H, CALDWELL C, Aaron D, Flatgaard J . Isozyme-specific glutathione-S-transferase inhibitors: design and synthesis. J Med Chem. 1994; 37(1):189-94. DOI: 10.1021/jm00027a024. View

Liu Y, Wu Y, Yu Y, Cao C, Zhang J, Li K . Curcumin and resveratrol in combination modulate drug-metabolizing enzymes as well as antioxidant indices during lung carcinogenesis in mice. Hum Exp Toxicol. 2015; 34(6):620-7. DOI: 10.1177/0960327114551396. View

Mukherjee S, Baidoo J, Fried A, Atwi D, Dolai S, Boockvar J . Curcumin changes the polarity of tumor-associated microglia and eliminates glioblastoma. Int J Cancer. 2016; 139(12):2838-2849. DOI: 10.1002/ijc.30398. View

Iersel M, Ploemen J, Struik I, van Amersfoort C, Keyzer A, Schefferlie J . Inhibition of glutathione S-transferase activity in human melanoma cells by alpha,beta-unsaturated carbonyl derivatives. Effects of acrolein, cinnamaldehyde, citral, crotonaldehyde, curcumin, ethacrynic acid, and trans-2-hexenal. Chem Biol Interact. 1996; 102(2):117-32. DOI: 10.1016/s0009-2797(96)03739-8. View

Li H, Chen X, Calhoun-Davis T, Claypool K, Tang D . PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Res. 2008; 68(6):1820-5. DOI: 10.1158/0008-5472.CAN-07-5878. View

10.

Wang J, Wang X, Zheng B, Wang Y, Wang X, Liang B . Curcumin inhibits the growth via Wnt/β-catenin pathway in non-small-cell lung cancer cells. Eur Rev Med Pharmacol Sci. 2018; 22(21):7492-7499. DOI: 10.26355/eurrev_201811_16290. View

11.

Tysnes B, Bjerkvig R . Cancer initiation and progression: involvement of stem cells and the microenvironment. Biochim Biophys Acta. 2007; 1775(2):283-97. DOI: 10.1016/j.bbcan.2007.01.001. View

12.

Kang J, Kang H, Kim I, Lee H, Ha J, Yeo C . Curcumin sensitizes human lung cancer cells to apoptosis and metastasis synergistically combined with carboplatin. Exp Biol Med (Maywood). 2015; 240(11):1416-25. PMC: 4935310. DOI: 10.1177/1535370215571881. View

13.

Duchartre Y, Kim Y, Kahn M . The Wnt signaling pathway in cancer. Crit Rev Oncol Hematol. 2016; 99:141-9. PMC: 5853106. DOI: 10.1016/j.critrevonc.2015.12.005. View

14.

Qi W, Chen J, Cheng X, Huang J, Xiang T, Li Q . Targeting the Wnt-Regulatory Protein CTNNBIP1 by microRNA-214 Enhances the Stemness and Self-Renewal of Cancer Stem-Like Cells in Lung Adenocarcinomas. Stem Cells. 2015; 33(12):3423-36. DOI: 10.1002/stem.2188. View

15.

Ge C, Wu S, Wang W, Liu Z, Zhang J, Wang Z . miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway. Oncotarget. 2015; 6(13):10964-77. PMC: 4484432. DOI: 10.18632/oncotarget.3696. View

16.

Tunc D, Dere E, Karakas D, Cevatemre B, Yilmaz V, Ulukaya E . Cytotoxic and apoptotic effects of the combination of palladium (II) 5,5-diethylbarbiturate complex with bis(2-pyridylmethyl)amine and curcumin on non small lung cancer cell lines. Bioorg Med Chem. 2017; 25(5):1717-1723. DOI: 10.1016/j.bmc.2017.01.043. View

17.

Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L . Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A. 2009; 106(38):16281-6. PMC: 2741477. DOI: 10.1073/pnas.0905653106. View

18.

Zhou Z, Ping Y, Yu S, Yi L, Yao X, Chen J . A novel approach to the identification and enrichment of cancer stem cells from a cultured human glioma cell line. Cancer Lett. 2009; 281(1):92-9. DOI: 10.1016/j.canlet.2009.02.033. View

19.

Ho M, Ng A, Lam S, Hung J . Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 2007; 67(10):4827-33. DOI: 10.1158/0008-5472.CAN-06-3557. View

20.

Sun F, Hu Y, Xiong L, Tu X, Zhao J, Chen S . Enhanced expression of stem cell markers and drug resistance in sphere-forming non-small cell lung cancer cells. Int J Clin Exp Pathol. 2015; 8(6):6287-300. PMC: 4525839. View